Navigation Links
BMP Sunstone Reports Second Quarter 2008 Financial Results
Date:8/11/2008

2 million in the second quarter of 2007. Sunstone contributed $19.6 million in revenues during the second quarter of 2008 and was not yet acquired in the prior year period. Revenues from licensed products were $1.4 million in the second quarter of 2008 as compared to $671,000 in the prior year period. Revenues from distribution were $8.6 million in the second quarter of 2008 compared to $6.5 million in the comparable period of 2007.

Non-GAAP gross profit increased to $16.7 million from $976,000 in the second quarter of 2007. This reflects a gross margin of 56.2%, which is a substantial year-over-year increase from 13.6% in the second quarter of 2007. The increase in gross margin was due to Sunstone revenue contribution, as well as increased licensed products sales, both carry a higher gross margin than distribution revenue.

Non-GAAP income from operations reached $3.2 million, compared with a non-GAAP loss of $1.2 million in the second quarter of 2007. General and administrative expenses as a percentage of revenue improved significantly decreasing to 10.8% of net revenues from 20.6% for 2007.

Non-GAAP net income was $1.3 million, or $0.03 per diluted share, relative to a net loss of $1.1 million, or ($0.04) per diluted share, in the second quarter of 2007.

David Gao, Chief Executive Officer of BMP Sunstone, stated, "Our second quarter 2008 results are the strongest achieved in the Company's history and we are particularly pleased with our operating profitability. Revenues were $29.6 million which is a $22.5 million increase over the same quarter of 2007 and non-GAAP income from operations was $3.2 million for the quarter as compare to a loss of $1.2 million for the prior year. We entered the second half focusing on our core growth drivers, namely, operational synergies, greater penetration of our existing therapeutic areas, product line extensions to leverage our leading brands and fully established distribution network to achieve continu
'/>"/>

SOURCE BMP Sunstone Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer
2. BMP Sunstone Receives Import Drug License (IDL) from SFDA
3. BMP Sunstone Receives SFDA Acceptance for Enablex(R) Clinical Trial
4. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
5. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
6. Pharmos Corporation Reports 2008 Second Quarter Results
7. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
8. Par Pharmaceutical Reports Second Quarter 2008 Results
9. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
10. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
11. Isis Reports Financial Results and Highlights for Second Quarter of 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015 PDL BioPharma, Inc. (PDL) ... conversion rate for the: , 3.75% Convertible Senior ... shares of common stock per $1,000 principal amount or approximately ... conversion rate for the note is adjusted in connection with ... March 12, 2015, to all stockholders who own shares of PDL ...
(Date:3/4/2015)... , Mar. 04, 2015 Research and ... the addition of Jain PharmaBiotech,s new report ... their offering. This report follows ... characteristic that can be objectively measured and evaluated ... processes as well as pharmacological responses to a ...
(Date:3/4/2015)... , March 4, 2015 AcelRx Pharmaceuticals, ... pharmaceutical company focused on the development and commercialization ... and breakthrough pain, today announced that it will ... after market close on Monday, March 9th, 2015. ... at 4:30 p.m. Eastern Time (1:30 p.m. Pacific ...
(Date:3/4/2015)... PARIS , March 4, 2015 ... Hopitaux de Paris en ... «   SARAH   », qui compare   ... l,yttrium-90 avec le   sorafénib dans le carcinome ... atteints d,un cancer du foie avancé   ; ...
Breaking Biology Technology:PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 3AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6
... Inc. (OTC: CSBR), today announced its operating results for its ... Fiscal 2011 Third Quarter Financial Highlights ... compared to the third quarter of 2010 ... of $796,000* Net loss of ($0.02) per ...
... the world of nanoparticles has now become a possibility, thanks ... UCSB research team has developed a new instrument capable of ... tens of nanometers. The study will be published on line ... the April print issue of the journal. "This ...
... Talecris Biotherapeutics Holdings Corp. (Nasdaq: TLCR ) ... 2011 as the record date for determining stockholders entitled to ... meeting will be held on May 3, 2011 at 9:00 ... House Lane, Chapel Hill, North Carolina. About ...
Cached Biology Technology:Champions Biotechnology Reports Fiscal 2011 Third Quarter Financial Results 2Champions Biotechnology Reports Fiscal 2011 Third Quarter Financial Results 3Champions Biotechnology Reports Fiscal 2011 Third Quarter Financial Results 4Champions Biotechnology Reports Fiscal 2011 Third Quarter Financial Results 5Champions Biotechnology Reports Fiscal 2011 Third Quarter Financial Results 6New instrument keeps an 'eye' on nanoparticles 2
(Date:2/12/2015)... Feb. 12, 2015   MedNet Solutions , ... clinical study management systems, has recently bolstered its ... distinguishing iMedNet as the ... (CROs) and healthcare consultants.  Building on the Program,s ... referrals and numerous co-marketing opportunities), MedNet,s new and ...
(Date:2/9/2015)... RICHARDSON, Texas , Feb. 9, 2015  Lintec ... novel fabrication methods for carbon nanotube (CNT) macrostructures, including ... Texas at Dallas (UTD). Leveraging the vast ... Tokyo, Japan , Lintec of America ... Richardson, TX , focusing on scaling ...
(Date:2/5/2015)... , Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... website ( http://www.nxt-id.com/ ) as part of its 2015 ... The Company launched its new consumer website for Wocketwallet.com ... , CEO of NXT-ID said, "Our new corporate website ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... Dalhousie University in Nova Scotia have identified a key ... growth if their findings are confirmed. In ... journal of the American Association for Cancer Research, lead ... Biochemistry and Molecular Biology and Pathology, and Canada Research ...
... it,s on to proteins, a much more daunting task. There ... molecules in our bodies. Many of these hold keys to ... Northwestern University chemical biologist Neil Kelleher has developed a new ... molecules quickly. Many have been skeptical that such an approach, ...
... major public symposium at Boston College will bring together four ... contributions of the physical and social sciences to a contemporary ... Liberal Arts University Why It Matters to Us All, ... the Liberal Arts, takes place today at the University,s main ...
Cached Biology News:Key driver of metastasis identified 2So many proteins, so much promise 2So many proteins, so much promise 3Science in the liberal arts university 2
... The TUNEL-based assay kit provides complete components ... convenient detection of DNA fragmentation in cultured ... an one-step labeling of apoptotic cells. ... of apoptosis in mammalian cells. MBLs ApoDIRECT ...
... imaging system allows imaging of fluorescent and ... 46cm at a pixel size as low ... suitable for protein electrophoresis in the proteomics ... Fuji s FLA-5100 includes four imaging solutions ...
... high speed and excellent temperature uniformity. Protocols ... Thermocycler can be run without any modifications. ... block for 48 or 96 wells. In ... in-situ applications are available. The High Precision ...
... The Sciclone inL10 Workstation from Caliper represents ... offering for the first time the ability ... automatically react to changing conditions. In ... in viscosity due to changes in temperature, ...
Biology Products: